Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function

Journal of Pathology

Volumn 233, Issue 4, 2014, Pages 331-343

  Roy, Sashwati ^a,b   Elgharably, Haytham ^a,b   Sinha, Mithun ^a,b   Ganesh, Kasturi ^a,b   Chaney, Sarah ^b   Mann, Ethan ^b   Miller, Christina ^b   Khanna, Savita ^b   Bergdall, Valerie K ^b   Powell, Heather M ^c   Cook, Charles H ^b   Gordillo, Gayle M ^a,b   Wozniak, Daniel J ^b   Sen, Chandan K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c The Ohio State University   (United States)

Author keywords

microRNA; mixed species biofilm; porcine burn wounds; transepidermal water loss (TEWL); wound biofilm

Indexed keywords

MICRORNA; MICRORNA 146A; PROTEIN ZO1; PROTEIN ZO2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOFILM; BURN; CONTROLLED STUDY; DEBRIDEMENT; EPIDERMIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FUNCTION; SKIN WATER LOSS; TIGHT JUNCTION; WOUND HEALING; YORKSHIRE PIG;

MICRORNA; MIXED-SPECIES BIOFILM; PORCINE BURN WOUNDS; TRANSEPIDERMAL WATER LOSS (TEWL); WOUND BIOFILM;

ACINETOBACTER BAUMANNII; ANIMALS; BIOFILMS; CELL MEMBRANE PERMEABILITY; DEBRIDEMENT; EPIDERMIS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MODELS, ANIMAL; PSEUDOMONAS AERUGINOSA; SKIN; SWINE; WOUND HEALING; ZONULA OCCLUDENS-1 PROTEIN; ZONULA OCCLUDENS-2 PROTEIN;

EID: 84904203301     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4360     Document Type: Article

References (59)

1. Sen CK, Gordillo GM, Roy S, et al., Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 2009; 17: 763-771.
2. Lopez D, Vlamakis H, Kolter R,. Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol Rev 2009; 33: 152-163.
3. James GA, Swogger E, Wolcott R, et al., Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
4. Hall-Stoodley L, Costerton JW, Stoodley P,. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2: 95-108.
5. Seth AK, Geringer MR, Hong SJ, et al., In vivo modeling of biofilm-infected wounds: a review. J Surg Res 2012; 178: 330-338.
6. Watters C, DeLeon K, Trivedi U, et al., Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med Microbiol Immunol 2013; 202: 131-141.
7. Watters C, Everett JA, Haley C, et al., Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms. Infect Immun 2014; 82: 92-100.
8. Dalton T, Dowd SE, Wolcott RD, et al., An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One 2011; 6: e27317.
9. Sullivan TP, Eaglstein WH, Davis SC, et al., The pig as a model for human wound healing. Wound Repair Regen 2001; 9: 66-76.
10. Gordillo GM, Bernatchez SF, Diegelmann R, et al., Preclinical models of wound healing: is man the model? Proceedings of the Wound Healing Society Symposium. Adv Wound Care (New Rochelle) 2013; 2: 1-4.
11. Geyer M, Markou A,. The role of preclinical models in the development of psychotropic drugs. In Neuropsychopharmacology: the Fifth Generation of Progress, Davis KL, (ed.) Lippincott Williams & Wilkins, Philadelphia, 2002; 445-454.
12. Davis SC, Ricotti C, Cazzaniga A, et al., Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16: 23-29.
13. Bjarnsholt T,. The role of bacterial biofilms in chronic infections. Acta Pathol Microbiol Immunol Scand (suppl) 2013: 1-51.
14. Calhoun JH, Murray CK, Manring MM,. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 2008; 466: 1356-1362.
15. Dallo SF, Weitao T,. Insights into Acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010; 23: 169-174.
16. CMS. Decision memo for electrostimulation for wounds (CAG-00068N), 2002.
17. Holloway BW, Krishnapillai V, Morgan AF,. Chromosomal genetics of Pseudomonas. Microbiol Rev 1979; 43: 73-102.
18. Roy S, Biswas S, Khanna S, et al., Characterization of a preclinical model of chronic ischemic wound. Physiol Genom 2009; 37: 211-224.
19. Elgharably H, Mann E, Awad H, et al., First evidence of sternal wound biofilm following cardiac surgery. PLoS One 2013; 8: e70360.
20. Roy S, Patel D, Khanna S, et al., Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci USA 2007; 104: 14472-14477.
21. Biswas S, Roy S, Banerjee J, et al., Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 2010; 107: 6976-6981.
22. Anderson GG, Moreau-Marquis S, Stanton BA, et al., In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 2008; 76: 1423-1433.
23. Zhao G, Hochwalt PC, Usui ML, et al., Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen 2010; 18: 467-477.
24. Chan YC, Roy S, Khanna S, et al., Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol 2012; 32: 1372-1382.
25. Roy S, Khanna S, Azad A, et al., Fra-2 mediates oxygen-sensitive induction of transforming growth factor-β in cardiac fibroblasts. Cardiovasc Res 2010; 87: 647-655.
26. Mehta RC, Stecker KK, Cooper SR, et al., Intercellular adhesion molecule-1 suppression in skin by topical delivery of anti-sense oligonucleotides. J Invest Dermatol 2000; 115: 805-812.
27. Parsek MR, Singh PK,. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
28. Martineau L, Davis SC, Peng HT, et al., Controlling methicillin-resistant Staphyloccocus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial. J Invest Surg 2007; 20: 217-227.
29. Tredget EE, Shankowsky HA, Groeneveld A, et al., A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998; 19: 531-537.
30. Whiteley M, Bangera MG, Bumgarner RE, et al., Gene expression in Pseudomonas aeruginosa biofilms. Nature 2001; 413: 860-864.
31. Perez-Osorio AC, Williamson KS, Franklin MJ,. Heterogeneous rpoS and rhlR mRNA levels and 16S rRNA/rDNA (rRNA gene) ratios within Pseudomonas aeruginosa biofilms, sampled by laser capture microdissection. J Bacteriol 2010; 192: 2991-3000.
32. Lenz AP, Williamson KS, Pitts B, et al., Localized gene expression in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2008; 74: 4463-4471.
33. Pinnagoda J, Tupker RA, Agner T, et al., Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164-178.
34. Pummi K, Malminen M, Aho H, et al., Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol 2001; 117: 1050-1058.
35. Kennedy P, Brammah S, Wills E,. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 2010; 36: 49-56.
36. Wolcott RD, Rhoads DD,. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008; 17: 145-148, 150-142, 154-145.
37. Gurjala AN, Geringer MR, Seth AK, et al., Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen 2011; 19: 400-410.
38. Kirketerp-Moller K, Jensen PO, Fazli M, et al., Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008; 46: 2717-2722.
39. Furuse M., Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010; 2: a002907.
40. Kirschner N, Rosenthal R, Gunzel D, et al., Tight junctions and differentiation-a chicken or the egg question? Exp Dermatol 2012; 21: 171-175.
41. Hartsock A, Nelson WJ,. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778: 660-669.
42. Monteiro AC, Sumagin R, Rankin CR, et al., JAM-A associates with ZO-2, Afadin and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function. Mol Biol Cell 2013; 24: 2849-2860.
43. Katsuno T, Umeda K, Matsui T, et al., Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 2008; 19: 2465-2475.
44. Xu J, Kausalya PJ, Phua DC, et al., Early embryonic lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development. Mol Cell Biol 2008; 28: 1669-1678.
45. Ireton K., Molecular mechanisms of cell-cell spread of intracellular bacterial pathogens. Open Biol 2013; 3: 130079.
46. Clark CA, Thomas LK, Azghani AO,. Inhibition of protein kinase C attenuates Pseudomonas aeruginosa elastase-induced epithelial barrier disruption. Am J Respir Cell Mol Biol 2011; 45: 1263-1271.
47. Yi R, O'Carroll D, Pasolli HA, et al., Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 2006; 38: 356-362.
48. Ye D, Guo S, Al-Sadi R, et al., MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology 2011; 141: 1323-1333.
49. Yang Y, Ma Y, Shi C, et al., Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. Biochem Biophys Res Commun 2013; 434: 746-752.
50. Tang Y, Banan A, Forsyth CB, et al., Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008; 32: 355-364.
51. Sonkoly E, Stahle M, Pivarcsi A,. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008; 18: 131-140.
52. Jurkin J, Schichl YM, Koeffel R, et al., miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation. J Immunol 2010; 184: 4955-4965.
53. Liu Z, Lu CL, Cui LP, et al., MicroRNA-146a modulates TGF-β1-induced phenotypic differentiation in human dermal fibroblasts by targeting SMAD4. Arch Dermatol Res 2012; 304: 195-202.
54. Xu J, Wu W, Zhang L, et al., The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes 2012; 61: 2906-291.
55. Forman JJ, Coller HA,. The code within the code: microRNAs target coding regions. Cell Cycle 2010; 9: 1533-1541.
56. Wang WX, Wilfred BR, Xie K, et al., Individual microRNAs (miRNAs) display distinct mRNA targeting 'rules'. RNA Biol 2010; 7: 373-380.
57. Zhang Y, Yang L, Gao YF, et al., MiR-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Mol Cell Endocrinol 2013; 381: 230-240.
58. Ma C, Wickham ME, Guttman JA, et al., Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol 2006; 8: 1669-1686.
59. Thomson CH,. Biofilms: do they affect wound healing? Int Wound J 2011; 8: 63-67.